{
    "title": "U.S. FDA accepts Biogen's ALS therapy for review",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-11049889/U-S-FDA-grants-priority-review-Biogens-ALS-drug.html",
    "date": "2022-07-26",
    "keywords": [
        "study",
        "tofersen",
        "biogen",
        "approval",
        "treatment",
        "drug",
        "company",
        "review",
        "latestage",
        "fda",
        "protein",
        "type",
        "sclerosis",
        "health",
        "regulator",
        "food",
        "decision",
        "priority",
        "jan",
        "meeting",
        "application",
        "gene",
        "accumulation",
        "sod1",
        "cause",
        "october",
        "goal",
        "improvement",
        "status",
        "june",
        "administration",
        "progression",
        "mutation",
        "neurofilament",
        "benefit",
        "benchmark",
        "flexibility",
        "neurodegeneration",
        "analyst",
        "paul",
        "matteis",
        "fdas",
        "pathway",
        "scrutiny",
        "year",
        "efficacy",
        "ionis",
        "reporting",
        "roy",
        "bengaluru",
        "editing",
        "shinjini",
        "ganguli"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}